Literature DB >> 9468059

Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics.

M Lück1, B R Paulke, W Schröder, T Blunk, R H Müller.   

Abstract

Plasma protein adsorption patterns on colloidal drug carriers acquired after i.v. administration depend on their surface characteristics and are regarded as key factors for their in vivo organ distribution. Polymeric latex particles with strongly differing surface properties were synthesized as models for colloidal drug carriers for tissue-specific drug targeting via the intravenous route. Physicochemical characterization was performed for size, surface charge density, zeta potential, and surface hydrophobicity. The interactions with human plasma proteins were studied by way of two-dimensional polyacrylamide gel electrophoresis (2-D PAGE). Considerable differences in protein adsorption on the latex particles were detected with regard to the total amount of surface-bound protein on the various particle types as well as specific proteins adsorbed, for example, fibrinogen, albumin, and a recently identified plasma glycoprotein. Possible correlations between protein adsorption patterns and the physicochemical characteristics and topography of the polymeric surfaces are shown and discussed. Knowledge about protein-nanoparticle interactions can be utilized for the rational design of colloidal drug carriers and also may be useful for optimizing implants and medical devices.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468059     DOI: 10.1002/(sici)1097-4636(19980305)39:3<478::aid-jbm19>3.0.co;2-6

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  26 in total

1.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

2.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.

Authors:  Martin Lundqvist; Johannes Stigler; Giuliano Elia; Iseult Lynch; Tommy Cedervall; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

3.  Understanding and overcoming major barriers in cancer nanomedicine.

Authors:  Shuming Nie
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

Review 4.  Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.

Authors:  Miloni Thakkar; Brijesh S
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

5.  Impact of Serum Proteins on MRI Contrast Agents: Cellular Binding and T2 relaxation.

Authors:  Alexandra Hill; Christine K Payne
Journal:  RSC Adv       Date:  2014       Impact factor: 3.361

6.  Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: a mechanistic study.

Authors:  Tobias Jung; Walter Kamm; Armin Breitenbach; Gerhard Klebe; Thomas Kissel
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

Review 7.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Authors:  Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E Toledano Furman; Francesco Salvatore; Ennio Tasciotti
Journal:  Nanomedicine (Lond)       Date:  2015-12-11       Impact factor: 5.307

8.  Biochemical and proteomic analysis of the magnetosome membrane in Magnetospirillum gryphiswaldense.

Authors:  Karen Grünberg; Eva-Christina Müller; Albrecht Otto; Regina Reszka; Dietmar Linder; Michael Kube; Richard Reinhardt; Dirk Schüler
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

Review 9.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

Review 10.  Nanotechnology: a focus on nanoparticles as a drug delivery system.

Authors:  Jeffrey D Kingsley; Huanyu Dou; Justin Morehead; Barrett Rabinow; Howard E Gendelman; Christopher J Destache
Journal:  J Neuroimmune Pharmacol       Date:  2006-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.